MWNA
ASMB icon

Marshall Wace North America’s Assembly Biosciences ASMB Stock Holding History

Marshall Wace North America’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-35,215
Closed -$6.95M – 1296
2020
Q3 		$6.95M Buy
35,215
+5,386
+18% +$1.36M 0.04% 338
2020
Q2 		$8.35M Buy
29,829
+13,128
+79% +$3.06M 0.06% 285
2020
Q1 		$2.97M Sell
16,701
-11,685
-41% -$2.5M 0.02% 409
2019
Q4 		$6.97M Buy
28,386
+27,760
+4,435% +$5.11M 0.03% 339
2019
Q3 		$74K Buy
+626
New +$94.7K ﹤0.01% 1102
2019
Q2 		– Sell
-369
Closed -$87K – 1141
2019
Q1 		$87K Buy
369
+242
+191% +$61.3K ﹤0.01% 1140
2018
Q4 		$34K Sell
127
-4,922
-97% -$1.42M ﹤0.01% 1336
2018
Q3 		$2.25M Sell
5,049
-3,958
-44% -$1.85M 0.02% 469
2018
Q2 		$4.24M Buy
9,007
+6,337
+237% +$3.35M 0.02% 562
2018
Q1 		$1.57M Buy
2,670
+2,167
+431% +$1.34M 0.01% 872
2017
Q4 		$273K Buy
+503
New +$228K ﹤0.01% 1242

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Marshall Wace North America's ASMB Position: Q4 2020 in Review

Marshall Wace North America sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 35,215 shares — an estimated $6.95M sold.

Marshall Wace North America first reported a position in ASMB in Q4 2017 and held it in 11 quarters. The position peaked at $8.35M in Q2 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Marshall Wace North America reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 35,215 Assembly Biosciences shares in Q4 2020, an estimated $6.95M.
  • Marshall Wace North America first reported a position in Assembly Biosciences in Q4 2017 and held it in 11 quarters.
  • Marshall Wace North America's Assembly Biosciences position peaked at $8.35M in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.